Natco Pharma has announced that Dr. Santhan Gopalakrishnan Vaidyanathan, Senior Vice President – ARD, will superannuate from the company, effective from the closure of business hours on September 30, 2025. This transition will mark the end of Dr. Vaidyanathan’s tenure in senior management at Natco Pharma.
Senior Management Transition
Dr. Santhan Gopalakrishnan Vaidyanathan, the Senior Vice President – ARD of Natco Pharma, will be superannuating from his position. This transition will occur effective at the close of business on September 30, 2025.
Key Details of Superannuation
The superannuation of Dr. Vaidyanathan will take effect as scheduled, leading to a change in the company’s senior management. More information will be provided as required.
Source: BSE
